why choose us

First received: February 13, 2023

Clinical Trial: Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoant

Brief Summary: The purpose of this study is to assess the safety and PK of teplizumab in participants with Stage 2 type 1 diabetes who are <8 years of age.

Read more